FindTrial
Sign In

Glucagon-like peptide-1 receptor agonists (GLP 1 RA)

DRUG4 trials

Sponsors

Bayer, Shanghai Chest Hospital, The University of Hong Kong, University of Pennsylvania

Conditions

Atrial Fibrillation (AF)Chronic Kidney DiseaseDiabetes Mellitus, Type 2Diabetic NephropathiesKidney DiseasesOsteoarthritis (OA) of the KneeRenal Insufficiency, ChronicType 2 Diabetes Mellitus

Early Phase 1

Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist
Not yet recruitingNCT06807970
The University of Hong KongOsteoarthritis (OA) of the Knee
Start: 2025-09-01End: 2028-07-01Target: 54Updated: 2025-09-03

Unknown Phase

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice
CompletedNCT05526157
BayerChronic Kidney Disease, Type 2 Diabetes Mellitus
Start: 2022-10-01End: 2024-09-05Updated: 2024-10-15
Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF
CompletedNCT06660134
Shanghai Chest HospitalAtrial Fibrillation (AF), Type 2 Diabetes Mellitus (T2DM)
Start: 2021-08-01End: 2024-01-10Updated: 2024-10-28
Transformative Research in Diabetic Nephropathy 2.0
RecruitingNCT07444203
University of PennsylvaniaDiabetes Mellitus, Type 2, Diabetic Nephropathies, Kidney Diseases +1
Start: 2025-11-12End: 2028-11-12Target: 200Updated: 2026-03-02

Related Papers

Temporal Changes in SGLT2 Inhibitor and GLP-1 Receptor Agonist Use in Patients with Chronic Kidney Disease and Type 2 Diabetes, 2012-2023: A US Cohort Study.
2025-12-09
Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study.
2025-03-191 citations
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.
2024-12-172 citations
#2505 CHARACTERISTICS OF MEDICATION-INITIATOR COHORTS OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES IN JAPAN: A REPORT FROM FOUNTAIN PLATFORM
Nephrology Dialysis Transplantation2023-06-01